Lilly, Roche to get expedited FDA review for blood test to diagnose Alzheimer’s disease
Roche and Lilly said they believe the test could play an important role in improving access to early and accurate Alzheimer’s diagnosis.
Roche and Lilly said they believe the test could play an important role in improving access to early and accurate Alzheimer’s diagnosis.
Meanwhile, demand for Lilly’s Zephound and Mounjaro is leading to a shortage of the drugs that is expected to last until at least mid-year, the FDA said in an update Wednesday.
The Indianapolis-based foundation, which announced the donation Friday, said the funds would help make mental health and behavioral health services more available to children and adolescents.
Noah Herron, with co-founders Mike Hayner and Marc Rupenthal, plans to open Urban Apples Cidery in May. It will be Hamilton County’s first cidery and the 15th cidery in Indiana, according to ciderguide.com.
Rarely a day goes without President Joe Biden mentioning insulin prices and promoting a $35 price cap for the medication for Americans on Medicare. The reality is more complicated.
The company plans to develop at least 12 buildings totaling more than 1.6 million square feet. The project is expected to anchor the LEAP Research and Innovation District northwest of Lebanon.
The map specifies more than 120 non-contiguous addresses throughout downtown that would be incorporated into a new professional sports development area, or PSDA.
Indiana’s strategy for economic development and job creation has emerged as a key issue in the Republican gubernatorial primary—and the future of the state’s still-developing LEAP district in Boone County could be at stake in the outcome.
Doctors and pharmacies have reported huge demand for Mounjaro and Zepbound in recent months, causing widespread shortages of the popular drugs.
More worries about inflation and interest rates staying high knocked U.S. stocks lower on Tuesday, as the market closed out its worst month since September.
Lilly and the Fever said they would also use the partnership “to close gaps on health outcomes in Indianapolis and across the state” by raising awareness of health issues.
The approval, the first step in the legislative process, came with nearly 100 Indy Eleven supporters packing a portion of the City-County Building Public Assembly Room to show their support for the team.
Eli Lilly and Novo are leading now, but there are multiple drug candidates waiting in the wings that could disrupt that duopoly in the future.
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood sugar and take off weight.
A report issued Monday by BioCrossroads says Indiana life sciences companies saw a decrease in capital and investments last year, but made a significantly higher contribution to the state’s economy than they did the previous year.
IBJ talked with State Agriculture Director Don Lamb about the trade mission to Brazil, the importance of agriculture trade missions and Indiana’s import/export relationships.
The U.S. Food and Drug Administration is convening a panel of independent experts on June 10 to discuss donanemab’s safety and effectiveness, including the results in patients in a clinical trial.
This is the third consecutive year that the pharmaceutical engineering consultant is among the Fast 25, and a fourth in 2025 wouldn’t be surprising.
During its quarter century of existence, BCforward has become one of the nation’s largest Black-owned businesses, employing some 5,000 workers around the world.
In a series of lawsuits Lilly filed in September and October in federal court, the drugmaker had accused Totality Medispa of trademark infringement, false advertising, unfair competition and unfair trade practices.